A Risk-Benefit Appraisal of Transdermal Estradiol Therapy
- 1 November 1993
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 9 (5) , 365-379
- https://doi.org/10.2165/00002018-199309050-00005
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Adverse dermatologic reactions to transdermal drug delivery systemsJournal of the American Academy of Dermatology, 1990
- Estrogen Therapy During MenopauseDrugs, 1990
- A Risk-Benefit Assessment of Estrogen Therapy in Postmenopausal WomenDrug Safety, 1990
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Contact dermatitis to transdermal estradiol systemJournal of the American Academy of Dermatology, 1989
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- The Effect of Estrogen Dose on Postmenopausal Bone LossNew England Journal of Medicine, 1983
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- Estrogen and progesterone in plasma in relation to premenstrual tensionJournal of Steroid Biochemistry, 1974